Stay updated on Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial
Sign up to get notified when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.

Latest updates to the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page
- Check6 days agoChange DetectedThe page now shows a server error indicating the page is unavailable, and the detailed study content has been removed, leaving an inaccessible study record for NCT03631407.SummaryDifference19%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3. This reflects a small backend/versioning update and does not change visible study information.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the prior v3.6.2, indicating a minor version update. This update is a software release note and does not affect the study content or visible functionality on the page.SummaryDifference0.0%

- Check48 days agoChange DetectedDifference0.0%

- Check63 days agoChange DetectedThe page adds a recruitment status line and new navigation/help sections, updates the Intervention/Treatment heading, and includes a revision tag (Revision: v3.6.0) replacing the previous version.SummaryDifference0.4%

- Check70 days agoChange DetectedThe revision tag on the page was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's version. No substantive study details are affected.SummaryDifference0.0%

Stay in the know with updates to Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.